KOREA WHO
-
-
President of SNUH
Kim Young-tae
Lung Cancer and Transplantation Expert Focuses on Strengthening Role of National Central Hospital Amid Medical Policy Disputes
-
Last Updated on Apr 11, 2025
-
President of SNUH
Copy Url : https://www.koreawho.com/profile/KimYoungtae- Life Summary
Kim Young-tae is the President and CEO of Seoul National University Hospital.
He is dedicated to elevating medical care and research to a global level and fulfilling public healthcare responsibilities as the nation's central hospital.
He was born on November 4, 1963, in Seoul.
He graduated from Seoul National University College of Medicine. He earned his master's and doctoral degrees in medicine from the graduate school of Seoul National University.
After completing his internship and residency at Seoul National University Hospital, he was appointed professor in the Department of Thoracic Surgery at Seoul National University College of Medicine.
He completed a fellowship at the Mayo Clinic in the United States and served as the Director of the Lung Cancer Center and the Cardiopulmonary Intensive Care Unit at Seoul National University Hospital.
He was one of the candidates recommended again after then-President Yoon Suk-yeol rejected the two candidates for hospital president recommended by the Seoul National University Hospital board.
He was the first in the world to identify the gene (KIF5B-RET fusion gene) that causes lung cancer.
He was the first in Korea to successfully perform a lung transplant surgery on an infant under the age of two.
He is pursuing changes in the authoritative decision-making structure at Seoul National University Hospital by emphasizing horizontal relationships among members.
#KimYoungtae #SeoulNationalUniversityHospital #lungcancer #thoracicsurgery #publichealthcare #KIF5BRET #MayoClinic #hospitalpresident #lungtransplant #medicalresearch
He is dedicated to elevating medical care and research to a global level and fulfilling public healthcare responsibilities as the nation's central hospital.
He was born on November 4, 1963, in Seoul.
He graduated from Seoul National University College of Medicine. He earned his master's and doctoral degrees in medicine from the graduate school of Seoul National University.
After completing his internship and residency at Seoul National University Hospital, he was appointed professor in the Department of Thoracic Surgery at Seoul National University College of Medicine.
He completed a fellowship at the Mayo Clinic in the United States and served as the Director of the Lung Cancer Center and the Cardiopulmonary Intensive Care Unit at Seoul National University Hospital.
He was one of the candidates recommended again after then-President Yoon Suk-yeol rejected the two candidates for hospital president recommended by the Seoul National University Hospital board.
He was the first in the world to identify the gene (KIF5B-RET fusion gene) that causes lung cancer.
He was the first in Korea to successfully perform a lung transplant surgery on an infant under the age of two.
He is pursuing changes in the authoritative decision-making structure at Seoul National University Hospital by emphasizing horizontal relationships among members.
#KimYoungtae #SeoulNationalUniversityHospital #lungcancer #thoracicsurgery #publichealthcare #KIF5BRET #MayoClinic #hospitalpresident #lungtransplant #medicalresearch
- Life Summary
- Career Highlights & Challenges
- · Ranked No.1 in Brand Power (K-BPI) for 25 Consecutive Years
- · Digital-Bio Innovation Forum Held to Present Future Medical Direction
- · Korea’s First “Korean Medical Large Language Model (LLM)” Developed
- · Donations Continue to Strengthen Essential Medical Services
- · Healthcare AI Institute Opens, Marking the Era of AI-Based Precision Medicine
- · Core Vision and Values Across Five Key Areas
- · Global Collaboration Boosts Overseas Expansion of Bio Industry
- · 1st Anniversary of Pediatric Critical Care Center, Nexon Donates KRW 300 Million
- · Pediatric Cancer and Rare Disease Initiative Enters Fourth Year with KRW 300 Billion Infrastructure Investment
- · Achieved INFRAM Stage 6 Certification, Recognized for Medical Infrastructure Standards
- · Seoul National University Hospital Renews Contract with UAE’s Sheikh Khalifa Specialty Hospital – First Korean Overseas Hospital with 10-Year Operation
- · “Companion Lounge” Opens as a Multi-Use Space for Cancer Patients
- · Busan Gijang Heavy Ion Therapy Center Begins Construction
- · Partnership with KRIBB to Strengthen National Strategic Technologies in Advanced Bio
- · Agreement Signed with National Medical Center to Establish Central Infectious Disease Hospital
- · Obstetrics Clinic for Women with Disabilities Opens
- · Kim Young-tae Inaugurated as Hospital President After 9-Month Vacancy
- · Seoul National University Hospital Overview
- Vision and Goals
- Market and Social Evaluation
- Notable Incidents & Legal Affairs
- - Construction Delayed for Baegot Seoul National University Hospital Due to Setbacks
- - Ranked Third in Korea in World Hospital Rankings
- - Seoul National University Hospital the Only One Rated 'B' Among Big 5
- - Receives Grade 4 in Integrity Assessment
- - Indefinite Strike Withdrawn After 3-Month Negotiation
- - Professors End Historic Walkout Amid Public Backlash Over Patient Inconvenience
- - Emergency Management Declared, Yet Hospital Director’s Pay Raise Sparks Controversy
- - Received 'B Grade' in Customer Satisfaction for Second Consecutive Year
- - Controversy Over Statement Supporting Increase in Medical School Quotas
- - Personal Information of 830,000 Patients Leaked
- - President Rejects Seoul National University Hospital Director Nomination for the First Time
- - “Board Structure and Election System Must Change,” Critics Say
- Professional Timeline
- Educational Background
- Awards & Recognitions
- Additional Information
- Notable Quotations
- Infographic & Photos